Understanding how a protein spreads from the gut to the brain in Parkinson's disease
Official title: Towards a comprehensive understanding of the neurotoxic spread of α-synuclein from gut to brain in Parkinson's disease
Funded at Augusta University · NIH-10910663 · Data updated 2026-11-12
This study is looking at how a protein linked to Parkinson's disease moves from the gut to the brain, using tiny worms to help find new ways to understand and potentially treat the disease.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Augusta University NIH-funded |
| Lab location | 1 site (Augusta, United States) |
| Project start | September 17, 2024 |
| Project end | August 31, 2027 |
| Funding year | 2024 |
| Award (this year) | $1,386,000 |
| NIH project number | 1DP2NS142716-01 |
| Project ID | NIH-10910663 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with Parkinson's disease or those at risk due to familial history or early symptoms.
✕Less likely to help
Patients with Parkinson's disease who are already in advanced stages of the disease may not benefit from this research.
What this research studies
This research investigates the mechanisms by which α-synuclein, a protein associated with Parkinson's disease, spreads from the gastrointestinal tract to the brain. Using the model organism C. elegans, the study aims to create new models that can help identify how this protein aggregation leads to neurodegeneration and behavioral changes. By mapping the spread of α-synuclein and examining different neuronal cell types, the research seeks to uncover the underlying processes that contribute to the disease. This approach allows for high-throughput screening to accelerate the discovery of potential therapeutic targets.
Why it matters
Potential benefit: If successful, this research could lead to new insights and potential treatments for Parkinson's disease, improving outcomes for patients.
How similar studies have gone: Other research has shown success in using model organisms like C. elegans to study neurodegenerative diseases, indicating that this approach has potential.
Where this research is happening
-
Augusta University
Augusta, United States Active
Researchers
- Principal investigator: Mor, Danielle Emille — Augusta University
- Study coordinator: Mor, Danielle Emille
Related research
Other NIH-funded projects on the same topics.
-
Gut-brain clues in Parkinson’s disease: supplement to a large registry
A plant-wide supplement to an NIH program will enroll people with Parkinson’s, with and without GI symptoms, plus healthy controls, to study how gut function, brain signals, and sleep rhythms relate to Parkinson’s symptoms.
-
Gut-brain connections in Parkinson’s disease: how the gut and environment shape symptoms
A Mayo Clinic team is studying how gut problems, environmental factors, and genetics together influence Parkinson’s disease and its GI symptoms to find biomarkers and better understanding of the disease.
-
Gut-brain communication in Parkinson’s disease for better symptoms and daily life
This project enrolls people with Parkinson’s disease and healthy controls to build a big registry and study how gut function, brain signals, sleep, and circadian rhythms relate to PD symptoms.
-
Gut microbiome and Parkinson's disease: how gut bugs relate to symptoms and progression
A multi-year study will look at gut bacteria and related markers in people with Parkinson’s disease to understand how the gut-brain connection may influence symptoms and progression.
-
Gut-Brain Axis in Parkinson’s Disease: biomarkers and procedures to track progression
A patient-focused program to study how gut health and the brain interact in Parkinson’s disease using biomarkers and clinical procedures.
-
Understanding posture and movement in Parkinson’s patients to reduce falls
A study using wearable sensors to track real-world balance and movement in people with Parkinson’s disease to help prevent falls.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.